| Budget Amount *help |
¥18,460,000 (Direct Cost: ¥14,200,000、Indirect Cost: ¥4,260,000)
Fiscal Year 2014: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2013: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2012: ¥9,750,000 (Direct Cost: ¥7,500,000、Indirect Cost: ¥2,250,000)
|
|---|
| Outline of Final Research Achievements |
Cancer progression should be understood with respect to cancer features as well as the biological response of the patient’ body. To concur cancers we need to understand tumor behaviors from early cancers to advanced ones. In this project we successfully clarified clinical significance of very early tumor cells, role of a key molecule involved in EMT, role of a hypoxic condition surrounding tumor cells in tumor progression, and we developed a novel nucleic acid medicine against therapy-resistant cancers.
|
